Co-Diagnostics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2016 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Co-Diagnostics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2016 to Q4 2024.
  • Co-Diagnostics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$11M, a 24.8% increase year-over-year.
  • Co-Diagnostics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$37.6M, a 6.53% decline year-over-year.
  • Co-Diagnostics, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$37.6M, a 6.53% decline from 2023.
  • Co-Diagnostics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$35.3M, a 148% decline from 2022.
  • Co-Diagnostics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$14.2M, a 139% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$37.6M -$11M +$3.65M +24.8% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-27
Q3 2024 -$41.3M -$9.7M -$3.71M -62.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$37.6M -$7.6M +$1.32M +14.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-07
Q1 2024 -$38.9M -$9.31M -$3.56M -61.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-07
Q4 2023 -$35.3M -$14.7M +$7.23M +33% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-27
Q3 2023 -$42.6M -$5.98M -$4.62M -340% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$37.9M -$8.92M -$6.23M -232% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-07
Q1 2023 -$31.7M -$5.76M -$17.5M -149% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-07
Q4 2022 -$14.2M -$21.9M -$29.4M -392% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 $15.2M -$1.36M -$12.8M -112% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $28M -$2.69M -$12.5M -127% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-09
Q1 2022 $40.5M $11.7M +$3.82M +48.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-09
Q4 2021 $36.7M $7.5M -$5.31M -41.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 $42M $11.5M -$4.26M -27.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $46.2M $9.79M -$5.22M -34.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 $51.4M $7.9M +$8.96M Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 $42.5M $12.8M +$14.5M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-24
Q3 2020 $27.9M $15.7M +$17.5M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $10.5M $15M +$16.3M Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-12
Q1 2020 -$5.89M -$1.07M +$303K +22.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-12
Q4 2019 -$6.2M -$1.74M +$213K +10.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-25
Q3 2019 -$6.41M -$1.75M -$107K -6.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$6.3M -$1.34M +$27.8K +2.03% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-16
Q1 2019 -$6.33M -$1.37M -$58.2K -4.44% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-16
Q4 2018 -$6.27M -$1.95M -$443K -29.4% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 -$5.83M -$1.64M +$2.25M +57.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$8.08M -$1.37M -$517K -60.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-12
Q1 2018 -$7.56M -$1.31M -$604K -85.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-12
Q4 2017 -$6.96M -$1.5M Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 -$3.89M -$3.44M -765% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$855K -$412K -93.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 -$706K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q3 2016 -$450K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$443K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.